Concord Medical Co., Ltd. (TPEX:6518)
Taiwan · Delayed Price · Currency is TWD 27.30
-0.05 (-0.18%)
At close: Mar 27, 2026
Concord Medical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 67.36 | 49.57 | 42.74 | 50.66 | 34.4 |
Depreciation & Amortization | 84.97 | 84.58 | 78.61 | 75.99 | 96.25 |
Other Amortization | - | 1.63 | 0.82 | 0.43 | 0.34 |
Loss (Gain) From Sale of Assets | -0.07 | -0.15 | -0.41 | -1.69 | -9.16 |
Loss (Gain) From Sale of Investments | -8.8 | - | - | - | - |
Provision & Write-off of Bad Debts | 0.03 | 1.02 | 0.17 | -0.69 | -1.84 |
Other Operating Activities | 0.79 | 3.35 | -5.33 | 3.91 | 3.63 |
Change in Accounts Receivable | 9.35 | 4.45 | 9.48 | -2.72 | 6.64 |
Change in Inventory | 0.2 | -1.43 | 2.02 | 3.18 | -6.53 |
Change in Accounts Payable | -4.78 | 4.32 | -15.14 | 17.83 | 0.67 |
Change in Other Net Operating Assets | 8.19 | 1.48 | 0.26 | 7.66 | 13.02 |
Operating Cash Flow | 157.24 | 148.83 | 113.23 | 154.56 | 137.42 |
Operating Cash Flow Growth | 5.65% | 31.45% | -26.74% | 12.47% | 63.47% |
Capital Expenditures | -33.82 | -74.72 | -88.18 | -37.46 | -21.8 |
Sale of Property, Plant & Equipment | 1.33 | 3.16 | 4.47 | 19.84 | 30.88 |
Cash Acquisitions | 1.83 | - | - | - | - |
Sale (Purchase) of Intangibles | -1.47 | -1.65 | -1.51 | -0.61 | 24.19 |
Sale (Purchase) of Real Estate | -3.71 | - | - | - | - |
Investment in Securities | -32.7 | -22.5 | -109 | -97.23 | - |
Other Investing Activities | 1.92 | 3.38 | 6.14 | 5.15 | -0.1 |
Investing Cash Flow | -66.62 | -92.33 | -188.08 | -110.31 | 33.17 |
Short-Term Debt Issued | 25.5 | - | - | - | - |
Long-Term Debt Issued | - | - | 35 | - | - |
Total Debt Issued | 25.5 | - | 35 | - | - |
Long-Term Debt Repaid | -64 | -24.69 | -22.11 | -19.58 | -120.69 |
Total Debt Repaid | -64 | -24.69 | -22.11 | -19.58 | -120.69 |
Net Debt Issued (Repaid) | -38.5 | -24.69 | 12.89 | -19.58 | -120.69 |
Issuance of Common Stock | - | - | - | - | 100 |
Common Dividends Paid | -36.67 | -33.33 | -33.33 | -16.67 | -10 |
Other Financing Activities | -0.02 | - | -40.35 | 40.11 | -0.53 |
Financing Cash Flow | -75.19 | -58.02 | -60.8 | 3.87 | -31.22 |
Net Cash Flow | 15.43 | -1.51 | -135.65 | 48.11 | 139.38 |
Free Cash Flow | 123.42 | 74.12 | 25.05 | 117.1 | 115.63 |
Free Cash Flow Growth | 66.52% | 195.91% | -78.61% | 1.27% | - |
Free Cash Flow Margin | 12.80% | 8.33% | 3.01% | 13.17% | 15.65% |
Free Cash Flow Per Share | 3.68 | 2.21 | 0.75 | 3.51 | 4.61 |
Cash Interest Paid | - | 3.55 | 3.52 | 3.51 | 4.79 |
Cash Income Tax Paid | - | 10.1 | 16.6 | 9.5 | 4.59 |
Levered Free Cash Flow | -53.01 | 54.59 | 16.19 | 108.82 | 121.36 |
Unlevered Free Cash Flow | -50.58 | 56.81 | 18.39 | 111.01 | 124.35 |
Change in Working Capital | 12.96 | 8.82 | -3.39 | 25.95 | 13.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.